- Report
- January 2024
- 165 Pages
Global
From €4505EUR$4,950USD£3,827GBP
- Report
- August 2022
- 108 Pages
Saudi Arabia
From €3049EUR$3,350USD£2,590GBP
- Report
- December 2023
- 204 Pages
Asia Pacific
From €3276EUR$3,599USD£2,782GBP
- Report
- December 2023
- 240 Pages
Latin America
From €3276EUR$3,599USD£2,782GBP
- Report
- December 2021
- 181 Pages
Global
From €4050EUR$4,450USD£3,440GBP
- Report
- February 2024
- 114 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2023
- 76 Pages
Asia Pacific
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2023
- 74 Pages
Europe
From €4323EUR$4,750USD£3,672GBP
- Report
- July 2023
- 82 Pages
Global
From €3500EUR$4,119USD£3,077GBP
The Feline Vaccine market is a segment of the Animal Pharmaceuticals industry that focuses on the development and distribution of vaccines for cats. Vaccines are used to protect cats from a variety of diseases, including feline leukemia, rabies, and feline infectious peritonitis. Vaccines are typically administered by veterinarians, and may be given as a single dose or as a series of doses. Vaccines are also available in a variety of forms, including injectable, oral, and intranasal.
The Feline Vaccine market is highly competitive, with a number of companies offering a wide range of products. Companies in the market include Merck Animal Health, Boehringer Ingelheim, Elanco, Zoetis, and Ceva Animal Health. These companies offer a variety of vaccines, including those for feline leukemia, rabies, and feline infectious peritonitis. Show Less Read more